Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)
Both the House and the Senate have competing bills aimed at addressing the rising costs of prescription drugs, a legislative priority backed by President Donald Trump.
But what would these various proposals accomplish, and how likely is it they’ll be signed into law?
[jwp-video n=”1″]
Recent Stories
Capitol Lens | Pipes of peace
Former House members reflect on 25th anniversary of Sept. 11 attacks
‘Tired of politics’: By GOP convention’s end, even Trump had tapped out
‘He’s not going away’: GOP loyalists not ready for Trump to leave political stage
Roll Call on the Road: Day Two in Dallas
Taxpayers spent more than $500,000 on House sexual harassment payouts